medicare coverage of glp 1 for weight loss Spending on Ozempic and Other GLP-1s Is Skyrocketing CMS Issues Coverage Guidance on

I was ashamed both that I needed the medication and that I was a hypocrite

If nausea is severe or persistent beyond week two, speak with your provider about dose adjustments or timing

People already prescribed GLP-1 by their GP Experiencing side effects, struggling with appetite changes, or feeling unsupported

Emerging data for the investigational anti-CD38 monoclonal antibody Felzartamab (targeting CD38+ plasma cells thought to produce pathogenic galactose-deficient IgA1 and anti-Gd-IgA1 autoantibodies) are especially promising in IgAN and have aspirations in transplant rejection (antibody-mediated rejection) and other complement-mediated renal diseases, underscoring the broader relevance of plasma-cell targeting in nephrology